Elderly Metastatic Breast Cancer: Pertuzumab-Herceptin vs Pertuzumab-Herceptin-Metronomic Chemotherapy, Followed by T-DM1
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Elderly Metastatic Breast Cancer Population
Interventions: DRUG: Pertuzumab + trastuzumab|DRUG: Pertuzumab + trastuzumab + metronomic chemotherapy
Sponsor: European Organisation for Research and Treatment of Cancer - EORTC
Collaborators: Hoffmann-La Roche